PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China · Delayed Price · Currency is CNY 26.75
+2.27 (9.27%)
At close: Aug 4, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 4.78 billion as of August 4, 2026. Its market cap has decreased by -8.27% in one year.
Market Cap
4.78B
Enterprise Value
4.65B
Revenue
691.21M
Ranking
n/a
PE Ratio
109.07
Stock Price
26.75
ChartMarket Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 4.78B, an increase of 21.45%. That is a compound annual growth rate of 5.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.78B | 16.42% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
| Nov 1, 2022 | 3.94B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 4.80B |
| Beijing Konruns Pharmaceutical | 4.69B |
| Suzhou Fengbei Biotech Stock | 4.67B |
| Xiangxue Pharmaceutical | 4.62B |
| R&G PharmaStudies | 4.53B |
| Shenzhen Weiguang Biological Products | 4.52B |
| ChemPartner PharmaTech | 4.46B |
| Anhui Huaheng Biotechnology | 4.24B |